1. Fujinaga Y, Wolf AA, Rodighiero C, Wheeler H, Tsai B, Allen L,
Jobling MG, Rapoport T, Holmes RK, Lencer WI: Gangliosides that
associate with lipid rafts mediate transport of cholera and
related toxins from the plasma membrane to endoplasmic
reticulm. Mol Biol Cell 2003, 14(12):4783-4793.
2. Sekura R, Moss J, Vaughan M: Pertussis toxin. Orlando , Academic
Press; 1985.
3. Bhakdi S, Tranum-Jensen J: Alpha-toxin of Staphylococcus
aureus. Microbiol Rev 1991, 55:733-751.
4. Bernheimer AW, Avigad LS: Partial characterization of aerolysin,
a lytic exotoxin from Aeromonas hydrophila. Infect
Immun 1974, 9(6):1016-1021.
5. Buckley JT, Halasa LN, Lund KD, MacIntyre S: Purification and
some properties of the hemolytic toxin aerolysin. Can J Biochem
1981, 59:430-436.
6. Pappenheimer AMJ: Diphtheria toxin. Annu Rev Biochem 1977,
46:69-94.
7. Mock M, Fouet A: Anthrax. Annu Rev Microbiol 2001, 55:647-671.
8. Minton NP: Molecular genetics of clostridial neurotoxins. Curr
Top Microbiol Immunol 1995, 195:161-194.
9. De SN: Enterotoxicity of bacteria-free culture filtrate of
Vibrio cholerae. nature 1959, 183:1533-1534.
10. Dutta NK, Panse MW, Kulkarni DR: Role of cholera toxin in
experimental cholera. J Bacteriol 1959, 78:594-595.
11. O'Brien AD, Holmes RK: Shiga and the Shiga-like toxins. Microbiol
Rev 1987, 51:206-220.
12. Iglewski BH, Kabat D: NAD-dependent inhibition of protein
synthesis by Pseudomonas aeruginosa toxin. Proc Natl Acad Sci
USA 1975, 72:2284-2288.
13. Balint GA: Ricin: the toxic protein of castor oil seeds. Toxicology
1974, 2:77-102.
14. Johannes L, Goud B: Surfing on a retrograde wave: how does
Shiga toxin reach the endoplasmic reticulum? Trends Cell Biol
1998, 8(4):158-162.
15. Lencer WI, Tsai B: The intracellular voyage of cholera toxin:
going retro. Trends Biochem Sci 2003, 28(12):639-645.
16. Lord JM, Roberts LM: Toxin entry: retrograde transport
through the secretory pathway. J Cell Biol 1998, 140(4):733-736.
17. Sandvig K, Grimmer S, Lauvrak SU, Torgersen ML, Skretting G, van
Deurs B, Iversen TG: Pathways followed by ricin and Shiga
toxin into cells. Histochem Cell Biol 2002, 117(2):131-141.
18. Hazes B, Read RJ: Accumulating evidence suggests that several
AB-toxins subvert the endoplasmic reticulum-associated
protein degradation pathway to enter target cells. Biochemistry
1997, 36(37):11051-11054.
19. Skehel JJ, Wiley DC: Receptor binding and membrane fusion in
virus entry: the influenza hemagglutinin. Annu Rev Biochem
2000, 69:531-569.
20. Blewitt MG, Chung LA, London E: Effect of pH on the conformation
of diphtheria toxin and its implications for membrane
penetration. Biochemistry 1985, 24(20):5458-5464.
21. Ochiai H, Sakai S, Hirabayashi T, Shimizu Y, Terasawa K: Inhibitory
effect of bafilomycin A1, a specific inhibitor of vacuolar-type
proton pump, on the growth of influenza A and B viruses in
MDCK cells. Antiviral Res 1995, 27(4):425-430.
22. Umata T, Moriyama Y, Futai M, Mekada E: The cytotoxic action of
diphtheria toxin and its degradation in intact Vero cells are
inhibited by bafilomycin A1, a specific inhibitor of vacuolartype
H(+)-ATPase. J Biol Chem 1990, 265(35):21940-21945.
23. van Deurs B, Sandvig K, Petersen OW, Olsnes S, Simons K, Griffiths
G: Estimation of the amount of internalized ricin that
reaches the trans-Golgi network. J Cell Biol 1988,
106(2):253-267.
24. Moss J, Vaughan M: Mechanism of action of choleragen: evidence
for ADP-ribosyltransferase activity with arginine as an
acceptor. J Biol Chem 1977, 252:2455-2457.
25. Kaper JB, Morris JG, Levine MM: Cholera. Clin MicrobiolRev 1995,
8:48-86.
26. Endo Y, Tsurugi K: RNA N-glycosidase activity of ricin A-chain.
Mechanism of action of the toxic lectin ricin on eukaryotic
ribosomes. J Biol Chem 1987, 262(17):8128-8130.
27. Endo Y, Tsurugi K, Yutsudo T, Takeda Y, Ogasawara T, Igarashi K:
Site of action of a Vero toxin (VT2) from Escherichia coli
O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA
N-glycosidase activity of the toxins. Eur J Biochem 1988, 171(1-
2):45-50.
28. Hale TL, Formal SB: Cytotoxicity of Shigella dysenteriae 1 for
cultured mammalian cells. Am J Clin Nutr 1980, 33(11
Suppl):2485-2490.
29. Holmgren J, Lonnroth I, Swennerholm I: Fixation and inactivation
of cholera toxin by GM1 gangliosides. Scand J Infect Dis 1973,
5:77-78.
30. Holmgren J, Lonnroth I, Swennerholm I: Tissue receptor for cholera
exotoxin: postulated structure from studies with GM1
ganglioside and related glycolipids. Infect Immun 1973,
8:208-214.
31. Waddell T, Cohen A, Lingwood CA: Induction of verotoxin sensitivity
in receptor-deficient cell lines using the receptor glycolipid
globotriosylceramide. Proc Natl Acad Sci U S A 1990,
87(20):7898-7901.
32. Jacewicz M, Clausen H, Nudelman E, Donohue-Rolfe A, Keusch GT:
Pathogenesis of shigella diarrhea. XI. Isolation of a shigella
toxin-binding glycolipid from rabbit jejunum and HeLa cells
and its identification as globotriaosylceramide. J Exp Med
1986, 163(6):1391-1404.
33. Lindberg AA, Brown JE, Stromberg N, Westling-Ryd M, Schultz JE,
Karlsson KA: Identification of the carbohydrate receptor for
Shiga toxin produced by Shigella dysenteriae type 1. J Biol
Chem 1987, 262:1779-1785.
34. Fraser ME, Fujinaga M, Cherney MM, Melton-Celsa AR, Twiddy EM,
O'Brien AD, James MN: Structure of shiga toxin type 2 (Stx2)
from Escherichia coli O157:H7. J Biol Chem 2004,
279(26):27511-27517.
35. Falguieres T, Mallard F, Baron C, Hanau D, Lingwood C, Goud B,
Salamero J, Johannes L: Targeting of Shiga toxin B-subunit to
retrograde transport route in association with detergentresistant
membranes. Mol Biol Cell 2001, 12(8):2453-2468.
36. Kovbasnjuk O, Edidin M, Donowitz M: Role of lipid rafts in Shiga
toxin 1 interaction with the apical surface of Caco-2 cells. J
Cell Sci 2001, 114(Pt 22):4025-4031.
37. Hoey DE, Currie C, Else RW, Nutikka A, Lingwood CA, Gally DL,
Smith DG: Expression of receptors for verotoxin 1 from
Escherichia coli O157 on bovine intestinal epithelium. J Med
Microbiol 2002, 51(2):143-149.
38. Thorpe CM, Hurley BP, Lincicome LL, Jacewicz MS, Keusch GT,
Acheson DW: Shiga toxins stimulate secretion of interleukin-
8 from intestinal epithelial cells. Infect Immun 1999,
67(11):5985-5993.
39. Gordon J, Challa A, Levens JM, Gregory CD, Williams JM, Armitage
RJ, Cook JP, Roberts LM, Lord JM: CD40 ligand, Bcl-2, and Bcl-xL
spare group I Burkitt lymphoma cells from CD77-directed
killing via Verotoxin-1 B chain but fail to protect against the
holotoxin. Cell Death Differ 2000, 7(9):785-794.
40. Tetaud C, Falguieres T, Carlier K, Lecluse Y, Garibal J, Coulaud D,
Busson P, Steffensen R, Clausen H, Johannes L, Wiels J: Two distinct
Gb3/CD77 signaling pathways leading to apoptosis are triggered
by anti-Gb3/CD77 mAb and verotoxin-1. J Biol Chem
2003.
41. Takenouchi H, Kiyokawa N, Taguchi T, Matsui J, Katagiri YU, Okita
H, Okuda K, Fujimoto J: Shiga toxin binding to globotriaosyl
ceramide induces intracellular signals that mediate cytoskeleton
remodeling in human renal carcinoma-derived cells. J
Cell Sci 2004, 117(Pt 17):3911-3922.
42. Olsnes S, Pihl A: Toxic lectins and related proteins. In Cohen P,
van Heyningen,S, editors Molecular action of toxins and viruses Amsterdam,
Elsevier 1982:51-105.
43. Spilsberg B, Van Meer G, Sandvig K: Role of lipids in the retrograde
pathway of ricin intoxication. Traffic 2003, 4(8):544-552.
44. Sandvig K, Olsnes S, Pihl A: Kinetics of binding of the toxic
lectins abrin and ricin to surface receptors of human cells. J
Biol Chem 1976, 251(13):3977-3984.
45. Spooner RA, Watson PD, Marsden CJ, Smith DC, Moore KA, Cook
JP, Lord JM, Roberts LM: Protein disulphide isomerase reduces
ricin to its A and B chains in the endoplasmic reticulum. Biochem
J 2004, 383:285-293.
46. Kounnas MZ, Morris RE, Thompson MR, FitzGerald DJ, Strickland
DK, Saelinger CB: The alpha2-macroglobulin receptor/low
de3nsity lipoprotein-related protein binds and internalizes
Pseudomonas exotoxin A. J Biol Chem 1992, 267:12420-12423.
47. Wedekind JE, Trame CB, Dorywalska M, Koehl P, Raschke TM,
McKee M, FitzGerald D, Collier RJ, McKay DB: Refined crystallographic
structure of Pseudomonas aeruginosa exotoxin A
and its implications for the molecular mechanism of toxicity.
J Mol Biol 2001, 314(4):823-837.
48. Sandvig K, Spilsberg B, Lauvrak SU, Torgersen ML, Iversen TG, van
Deurs B: Pathways followed by protein toxins into cells. Int J
Med Microbiol 2004, 293(7-8):483-490.
49. Tsai B, Gilbert JM, Stehle T, Lencer W, Benjamin TL, Rapoport TA:
Gangliosides are receptors for murine polyoma virus and
SV40. Embo J 2003, 22(17):4346-4355.
50. Anderson HA, Chen Y, Norkin LC: Bound simian virus 40 translocates
to caveolin-enriched membrane domains, and its
entry is inhibited by drugs that selectively disrupt caveolae.
Mol Biol Cell 1996, 7(11):1825-1834.
51. Pelkmans L, Puntener D, Helenius A: Local actin polymerization
and dynamin recruitment in SV40-induced internalization of
caveolae. Science 2002, 296(5567):535-539.
52. Stang E, Kartenbeck J, Parton RG: Major histocompatibility complex
class I molecules mediate association of SV40 with caveolae.
Mol Biol Cell 1997, 8(1):47-57.
53. Gilbert JM, Goldberg IG, Benjamin TL: Cell penetration and trafficking
of polyomavirus. J Virol 2003, 77(4):2615-2622.
54. Gilbert JM, Benjamin TL: Early steps of polyomavirus entry into
cells. J Virol 2000, 74(18):8582-8588.
55. Richterova Z, Liebl D, Horak M, Palkova Z, Stokrova J, Hozak P, Korb
J, Forstova J: Caveolae are involved in the trafficking of mouse
polyomavirus virions and artificial VP1 pseudocapsids
toward cell nuclei. J Virol 2001, 75(22):10880-10891.
56. Damm EM, Pelkmans L, Kartenbeck J, Mezzacasa A, Kurzchalia T,
Helenius A: Clathrin- and caveolin-1-independent endocytosis:
entry of simian virus 40 into cells devoid of caveolae. J Cell
Biol 2005, 168(3):477-488.
57. Ghosh RNMWGSTTMGTEMFR: An endocytosed TGN38 chimeric
protein is delivered to the TGN after trafficking
through the endocytic recycling compartment in CHO cells.
J Cell Biol 1998, 142:923-936.
58. Mallard F, Antony C, Tenza D, Salamero J, Goud B, Johannes L:
Direct pathway from early/recycling endosomes to the Golgi
apparatus revealed through the study of shiga toxin B-fragment
transport. J Cell Biol 1998, 143(4):973-990.
59. Mallard F, Tang BL, Galli T, Tenza D, Saint-Pol A, Yue X, Antony C,
Hong W, Goud B, Johannes L: Early/recycling endosomes-to-
TGN transport involves two SNARE complexes and a Rab6
isoform. J Cell Biol 2002, 156(4):653-664.
60. Mallet WG, Maxfield FR: Chimeric forms of furin and TGN38
are transported with the plasma membrane in the trans-
Golgi network via distinct endosomal pathways. J Cell Biol
1999, 146:345-359.
61. Lombardi D, Soldati T, Riederer MA, Goda Y, Zerial M, Pfeffer SR:
Rab9 functions in transport between late endosomes and the
trans Golgi network. Embo J 1993, 12(2):677-682.
62. Tai G, Lu L, Wang TL, Tang BL, Goud B, Johannes L, Hong W: Participation
of the syntaxin5/Ykt6/GS28/GS15 SNARE complex
in transport from the early/recycling endosomes to the
trans-Golgi network. Mol Biol Cell 2004, 15:4011-4022.
63. Lu L, Tai G, Hong W: Autoantigen Golgin-97, an effector of
Arl1 GTPase, participates in traffic from the endosome to
the trans-golgi network. Mol Biol Cell 2004, 15(10):4426-4443.
64. Sugimoto Y, Ninomiya H, Ohsaki Y, Higaki K, Davies JP, Ioannou YA,
Ohno K: Accumulation of cholera toxin and GM1 ganglioside
in the early endosome of Niemann-Pick C1-deficient cells.
Proc Natl Acad Sci U S A 2001, 98(22):12391-12396.
65. Nichols BJ: A distinct class of endosome mediates clathrinindependent
endocytosis to the Golgi complex. Nature Cell Biol
2002, 15:15.
66. Nichols BJ, Kenworthy AK, Polishchuk RS, Lodge R, Roberts TH, Hirschberg
K, Phair RD, Lippincott-Schwartz J: Rapid cycling of lipid
raft markers between the cell surface and Golgi complex. J
Cell Biol 2001, 153(3):529-541.
67. Vidricaire G, Tremblay MJ: Rab5 and Rab7, but not ARF6, govern
the early events of HIV-1 infection in polarized human
placental cells. J Immunol 2005, 175(10):6517-6530.
68. Smith DC, Spooner RA, Watson PD, Murray JL, Hodge TW, Amessou
M, Johannes L, Lord JM, Roberts LM: Internalised Pseudomonas
exotoxin A can exploit multiple pathways to reach
the endoplasmic reticulum. Traffic 2006, 7:379-393.
69. Iversen TG, Skretting G, Llorente A, Nicoziani P, van Deurs B, Sandvig
K: Endosome to Golgi transport of ricin is independent of
clathrin and of the Rab9- and Rab11-GTPases. Mol Biol Cell
2001, 12(7):2099-2107.
70. Grimmer S, Iversen TG, van Deurs B, Sandvig K: Endosome to
Golgi transport of ricin is regulated by cholesterol. Mol Biol
Cell 2000, 11(12):4205-4216.
71. Moisenovich M, Tonevitsky A, Maljuchenko N, Kozlovskaya N, Agapov
I, Volknandt W, Bereiter-Hahn J: Endosomal ricin transport:
involvement of Rab4- and Rab5-positive compartments. Histochem
Cell Biol 2004, 121(6):429-439.
72. Miesenbock G, Rothman JE: The capacity to retrieve escaped ER
proteins extends to the trans-most cisterna of rthe Golgi
stack. J Cell Biol 1995, 129:309-319.
73. Cosson P, Letourner F: Coatomer (COP1)-coated vesicles: role
in intracellular transport and protein sorting. Curr Opin Cell Biol
1997, 7:484-487.
74. Letourner F, Gaynor EC, Hennecke S, Demolliere C, Duden R, Emr
SD, Riezman H, Cosson P: Coatomer is essential for retrieval of
dilysine-tagged proteins to the endoplasmic reticulum. Cell
1994, 79:1199-1207.
75. Chaudary V, Jinno Y, FitzGerald D, Pastan I: Pseudomonas exotoxin
contains a specific sequence at the carboxyl terminus
that is required for cytotoxicity. Proc Natl Acad Sci USA 1990,
87:308-312.
76. Jackson ME, Simpson JC, Girod A, Pepperkok R, Roberts LM, Lord JM:
The KDEL retrieval system is exploited by Pseudomonas
exotoxin A, but not by Shiga-like toxin-1, during retrograde
transport from the Golgi complex to the endoplasmic reticulum.
J Cell Sci 1999, 112 ( Pt 4):467-475.
77. Kreitman RJ, Pastan I: Importance of the glutamate residue of
the KDEL in increasing the cytotoxicity of Pseudomonas
exotoxinderivatives and for increased binding to the KDEL
receptor. Biochem J 1995, 307:29-37.
78. Seetharam S, Chaudhary VK, FitzGerald D, Pastan I: Increased cytotoxic
activity of Pseudomonas exotoxin and two chimeric
toxins ending in KDEL. J Biol Chem 1991, 266(26):17376-17381.
79. Bard F, Mazelin L, Pechoux-Longin C, Malhotra V, Jurdic P: Src regulates
Golgi structure and KDEL receptor-dependent retrograde
transport to the endoplasmic reticulum. J Biol Chem
2003, 278(47):46601-46606.
80. Girod A, Storrie B, Simpson JC, Johannes L, Goud B, Roberts LM,
Lord JM, Nilsson T, Pepperkok R: Evidence for a COP-I-independent
transport route from the Golgi complex to the
endoplasmic reticulum. Nat Cell Biol 1999, 1(7):423-430.
81. White J, Johannes L, Mallard F, Girod A, Grill S, Reinsch S, Keller P,
Tzschaschel B, Echard A, Goud B, Stelzer EH: Rab6 coordinates a
novel Golgi to ER retrograde transport pathway in live cells.
J Cell Biol 1999, 147(4):743-760.
82. Monier S, Jollivet F, Janoueix-Lerosey I, Johannes L, Goud B: Characterization
of novel Rab6-interacting proteins involved in
endosome-to-TGN transport. Traffic 2002, 3(4):289-297.
83. Feng Y, Jadhav AP, Rodighiero C, Fujinaga Y, Kirchausen T, Lencer
WI: Retrograde transport of cholera toxin from the plasma
membrane to the endoplasmic reticulum requires the trans-
Golgi network but not the Golgi apparatus in Exo2-treated
cells. EMBO Rep 2004, 5:596-601.
84. Day PJ, Owens SR, Wesche J, Olsnes S, Roberts LM, Lord JM: An
interaction between ricin and calreticulin that may have
implications for toxin trafficking. J Biol Chem 2001,
276(10):7202-7208.
85. Chen A, AbuJarour RJ, Draper RK: Evidence that the transport
of ricin to the cytoplasm is independent of both Rab6A and
COPI. J Cell Sci 2003, 116(Pt 17):3503-3510.
86. Mannova P, Forstova J: Mouse polyomavirus utilizes recycling
endosomes for a traffic pathway independent of COPI vesicle
transport. J Virol 2003, 77(3):1672-1681.
87. Richards AA, Stang E, Pepperkok R, Parton RG: Inhibitors of COPmediated
transport and cholera toxin action inhibit simi